Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
- Registration Number
- NCT00370786
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
- Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.
Exclusion Criteria
- Evidence of AMD
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 bevacizumab -
- Primary Outcome Measures
Name Time Method Visual acuity 6 months
- Secondary Outcome Measures
Name Time Method central macular thickness 6 months leakage in fluorescein angiography 6 months
Trial Locations
- Locations (1)
Hamid Ahmadieh, MD
🇮🇷Tehran, Iran, Islamic Republic of
Hamid Ahmadieh, MD🇮🇷Tehran, Iran, Islamic Republic of